JCJaime Camacho-Mackenzie

Jaime Camacho-Mackenzie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jaime Camacho-Mackenzie has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Partial cardiopulmonary bypass in thoracoabdominal aorta repair: a safe alternative in a low-volume center

    by Nicolas Nunez-Ordonez, Julian Senosiain, Juan Andres Sarmiento, Carlos A. Villa, Carlos Obando, Tomas Chalela, Mauricio Palomino, Sergio A. Ortigoza-Espitia, Ivonne Pineda-Rodriguez, Nestor Sandoval, et al.

    To describe postoperative outcomes with the use of partial CPB for thoracoabdominal aortic repair. We included all the patients who underwent programmed th

  • Open Access

    Clinical Outcomes After Transcatheter Aortic Valve Replacement in Patients With Concomitant Mitral Regurgitation

    by Nicolas Nunez–Ordonez, Maria Jose Rozo, Jaime Cabrales, Dario Echeverri, Carlos Villa-Hincapie, Tomas Chalela, Carlos Obando, Lina Ramirez, Juan Andres Sarmiento, Jose Vicente Alvarez-Martinez, et al.

    Objectives: To describe the clinical outcomes of patients with severe aortic valve stenosis (AS) and concomitant mitral regurgitation (MR) undergoing transcatheter aortic valve replacement (TAVR) Methods: A propensity‐score matched analysis including 267 patients who underwent TAVR between 2009 and 2023. Information on pre‐, intra‐, and postoperative variables was collected. The main outcomes were survival and freedom from readmission for heart failure on long term follow‐up comparing the group with significant MR (sMR) (moderate–severe) vs. the control group. Results: The prevalence of sMR was 22%. TAVR improved the severity of MR in 65% of the patients. There were no significant differences on the main early postoperative outcomes. sMR was not associated with a lower survival on long‐term follow‐up but readmission for heart failure was higher in this group. Conclusions: MR is highly prevalent in patients undergoing TAVR. The procedure has a beneficial effect on the severity of concomitant MR. sMR was not associated with a higher mortality in long‐term follow‐up, patients with sMR experience a significant improvement in symptoms after TAVR although sMR was associated with higher heart failure readmissions.

  • Open Access

    22‐Year Experience With Valve‐Sparing Aortic Root Replacement in a Latin American Center

    by Juan David Niño-Calvera, Julian Senociain, Jaime Camacho, Nicolas Nunez-Ordonez, Carlos Obando, Tomas Chalela, Carlos Villa, Nestor Sandoval, Juan P. Umaña

    Objective: Describe the short‐ and long‐term outcomes of valve‐sparing aortic root replacement for aortic root aneurysm repair in a lower‐volume center Methods: We included patients with aortic root aneurysm who underwent the David procedure from January 2002 to June 2024 at our institution, identified by the institutional cardiac surgery database that follows the coding guidelines of the STS. We collected data from pre‐, intra‐, and postoperative periods. Follow‐up was performed through the outpatient clinic, government databases, and telephone interviews. The main outcomes were survival, valve regurgitation recurrence, and freedom from reoperation. Results: 150 patients were identified in 22 years. The mean age was 52 years, 81% were male, and the most frequent comorbidity was hypertension. 23 patients had Marfan syndrome and a bicuspid aortic valve. 47% of patients had severe AR, and 15% had moderate AR. 65% patients underwent elective surgery. There was concomitant aortic arch repair in 6 patients, mitral valve repair in 10 patients, and one patient required descending aorta repair. There was one perioperative death. Freedom from significant AR was 92% at 9 years, and freedom from reoperation was 90% at 8 years. There were 8 valve‐related reoperations and 11 deaths in the follow‐up period. Survival was 97% after 10 years. Conclusions: Valve‐sparing aortic root replacement is a safe procedure that provides outstanding short‐ and long‐term outcomes. In the long term, AR improvement is remarkable and maintainable. In our background, the David procedure has shown favorable outcomes comparable to those reported in high‐volume income centers.

  • Open Access

    A Retrospective Cohort Study Comparing Different Cannulation Strategies in Type A Aortic Dissection Surgery: 20-year Single-Center Experience in a Referral Center

    by Nicolas Nunez-Ordonez, Julian Senociain, Juan Pablo Umaña, Andres Felipe Amado-Olivares, Carlos Andrés Villa, Carlos Obando, Jaime Camacho

    Type A aortic dissection as a highly lethal disease continues being a great challenge for cardiac surgeons worldwide. There are still unanswered questions regarding intraoperative decisions and their impact on the surgical outcomes. The aim of this study is to compare postoperative outcomes according to site of cannulation in patients with acute Type A aortic dissection (ATAAD).This was a retrospective cohort study. We included all ATAAD procedures from January 2002 to November 2023. We defined groups according to site of cannulation (aorta, axillary, femoral, innominate). Data from pre-, intra-, and postoperative variables were collected. Our main outcomes were spinal cord injury (SCI), stroke rate, and in-hospital mortality. Between-group comparisons were performed using standard statistical tests and post hoc tests adjusting for multiple comparisons were performed.We identified 127 ATAAD procedures. Reoperation for bleeding was significantly higher in the femoral cannulation group (75%, p = 0.0006). There were no statistically significant differences in acute kidney injury rate (p = 0.012), SCI rate (p = 0.78), or in-hospital mortality (p = 0.75). Our data suggest that there is a lower stroke rate in the axillary cannulation group (3.6%, p = 0.4), which did not reach statistical significance.Choosing an adequate cannulation site is a critical step in TAAD surgery. In our series, axillary and innominate cannulation were the preferred methods with relatively low complication rates.


  • Open Access

    Management of embolic splenic abscess secondary to aortic valve endocarditis – case report and review of literature

    by Nicolas Nunez-Ordonez, Juan Sebastián Luna, Jaime Camacho Mackenzie, Andrés Felipe Jiménez, Alejandro González, Andrea J. Pico, Carlos F. Román, Paulo A. Cabrera Rivera, Carlos A. Villa Hincapié

    Background: Splenic abscess is a serious complication associated with infective endocarditis. There is still contradicting evidence regarding the optimal treatment pathway including timing of valve intervention and the approach for managing splenic foci. Case presentation: We present a case of a hybrid staged approach in which we successfully performed a laparoscopic splenectomy following percutaneous abscess drainage and a delayed aortic valve replacement. Conclusions: A multidisciplinary teamwork is fundamental in providing optimal care for patients with distant complications associated with infective endocarditis. Our hybrid approach seems safe and feasible.


  • Open Access

    Endovascular Repair of a Spontaneous Popliteal Arteriovenous Fistula Associated With a Venous Aneurysm

    by Sebastián Gómez-Galán, Alejandro Velandia-Sánchez, Lina María Sanabria-Arévalo, Camilo Andrés Polania-Sandoval, Sebastian Gallo-Bernal, Jaime Cabrales-Arévalo, Jaime Camacho-Mackenzie, Juan Guillermo Barrera-Carvajal

    Popliteal arteriovenous fistulae (PAF) are anomalous communications between the arterial and venous systems of the lower extremity. They are usually secondary to trauma and are rarely associated with additional vascular defects. The coexistence of a PAF and a venous aneurysm is rare and usually occurs in patients with connective tissue disorders. Evidence regarding the management of this type of anomaly is scarce. However, both open and endovascular approaches seem feasible alternatives for treating this condition. Here, we describe a spontaneous popliteal arteriovenous fistula associated with a venous aneurysm in a 42-year-old male patient who presented with a popliteal mass. Satisfactory endovascular closure of the fistula and exclusion of the venous aneurysm were achieved using an Amplatzer™ Vascular Plug II.


  • Open Access

    Surgical management of a giant right coronary artery aneurysm with coronary arteriovenous fistula: case report

    by Albert Franz Guerrero Becerra, Andres Mauricio Palacio, Jaime Camacho, Nestor Sandoval

    Background: Coronary artery aneurysms (CAAs) are uncommon, and giant aneurysms (>2 cm) are even more unusual. Coronary atherosclerosis and Kawasaki disease are the leading causes for this pathology. The treatment for this condition is controversial because the evidence is based on case report series. Case summary: We describe the case of a 77-year-old female patient who presented with heart failure symptoms. She was diagnosed with a giant saccular aneurysm arising from the right coronary artery (RCA) ostium and a fistula between the RC and the left anterior descending artery (LAD) to the coronary sinus. And an atrial septal defect (ASD) and severe tricuspid regurgitation were also found. The patient underwent surgery through a medium sternotomy, the aneurysm was opened and resected under cardiopulmonary bypass. The RCA was ligated at the distal end of the aneurysm, and a saphenous vein graft bypass was performed. A coronary arteriovenous fistula from the distal portion of RC and LAD artery to a severely enlarged coronary sinus was found and corrected with an autologous pericardial patch. Closure of the ASD was performed with a pericardial patch and a tricuspid ring annuloplasty was done. Post-operative course was uneventful. Discussion: There are few cases of giant coronary aneurysms associated with fistulas reported in the literature. Despite the endovascular percutaneous techniques available to treat these patients, we believe that surgical treatment was the best option for this particular case. We consider that surgical treatment is a very good option for giant CAAs associated with AV fistulas that are not susceptible for current endovascular available devices. The literature lacks evidence regarding the best approach for these cases, and we think that invasive treatment should be tailored according to the heart’s anatomy and patient risk.